The underlying mechanism for this association is that the NAFLD is strongly associated with both hepatic and adipose tissue insulin resistance as well as reduced whole-body insulin sensitivity [29]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.